PELLICCIOTTA, MARTINA
 Distribuzione geografica
Continente #
NA - Nord America 124
AS - Asia 109
EU - Europa 36
SA - Sud America 19
Continente sconosciuto - Info sul continente non disponibili 7
AF - Africa 1
Totale 296
Nazione #
US - Stati Uniti d'America 121
SG - Singapore 65
CN - Cina 21
BR - Brasile 14
VN - Vietnam 14
DE - Germania 10
IT - Italia 10
FI - Finlandia 6
HK - Hong Kong 5
GB - Regno Unito 3
IN - India 3
AR - Argentina 2
CA - Canada 2
CH - Svizzera 2
NL - Olanda 2
BD - Bangladesh 1
DZ - Algeria 1
EC - Ecuador 1
FR - Francia 1
GT - Guatemala 1
NO - Norvegia 1
PE - Perù 1
PL - Polonia 1
VE - Venezuela 1
Totale 289
Città #
Singapore 27
Ashburn 24
San Jose 24
Munich 9
The Dalles 9
Ho Chi Minh City 8
Beijing 7
Council Bluffs 7
Turku 6
Shanghai 5
Hanoi 4
Hong Kong 4
Santa Clara 4
Dallas 3
Los Angeles 3
Phoenix 3
Amsterdam 2
Atlanta 2
New York 2
Abbeville 1
Aimorés 1
Alexandria 1
Algiers 1
Alvorada 1
Anchorage 1
Austin 1
Bakersfield 1
Belo Horizonte 1
Berazategui 1
Burlington 1
Caracas 1
Cariacica 1
Christopher 1
Concordia 1
Guangzhou 1
Guatemala City 1
Itapecerica da Serra 1
Jacksonville 1
Jaraguá 1
Liberty 1
Lima 1
Limburg an der Lahn 1
Magé 1
Manhuaçu 1
Marseille 1
Mason 1
Milan 1
Moultrie 1
Mumbai 1
Naples 1
Newark 1
Nossa Senhora da Glória 1
Orem 1
Osasco 1
Oslo 1
Ponta Grossa 1
Quito 1
Quận Bảy 1
Repentigny 1
Reseda 1
Richmond 1
Rio Claro 1
San Francisco 1
Seattle 1
São José do Egito 1
São Paulo 1
Temple Hills 1
Topeka 1
Toronto 1
Utan 1
Warsaw 1
Yverdon-les-Bains 1
Totale 206
Nome #
GRAd-COV2 vaccine provides potent and durable humoral and cellular immunity to SARS-CoV-2 in randomized placebo-controlled phase 2 trial 58
Compassionate remdesivir treatment of severe Covid-19 pneumonia in intensive care unit (ICU) and Non-ICU patients: Clinical outcome and differences in post-treatment hospitalisation status 54
One-year durability of anti-spike IgG to SARS-CoV-2: Preliminary data from the anticrown prospective observational study one year durability of COVID-19 anti-spike IgG 50
Decay rate of antiS1/S2 IgG serum levels after 6 months of BNT162b2 vaccination in a cohort of COVID-19-naive and COVID-19-experienced subjects 47
Persistence of Long-COVID symptoms in a heterogenous prospective cohort 45
Comorbidity Burden and Suboptimal Immunological Responses to Coronavirus Disease 2019 Vaccination in People Living with Human Immunodeficiency Virus 42
Totale 296
Categoria #
all - tutte 1.581
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.581


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2024/202585 0 0 0 0 7 16 4 2 13 12 13 18
2025/2026165 26 14 2 10 11 5 51 7 13 15 2 9
2026/202746 4 10 27 5 0 0 0 0 0 0 0 0
Totale 296